Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Moderna to acquire OriCiro Genomics

Moderna to acquire OriCiro Genomics
Share on FacebookShare on Twitter

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, announced on Jan 4, 2023, that they have entered into a definitive agreement through which Moderna will acquire OriCiro for $85 million.

“With this acquisition, we obtain best-in-class tools for cell-free synthesis and amplification of plasmid DNA, a key building block in mRNA manufacturing,” said Stéphane Bancel, Chief Executive Officer of Moderna.

“OriCiro’s technology strategically complements our manufacturing expertise and further accelerates our research and development engine. We look forward to welcoming the OriCiro team to Moderna.”

“Moderna has demonstrated remarkable speed and ability to impact lives through their innovative platform and mRNA therapeutics. I am confident that our technology and talent will be a highly strategic fit with Moderna,” said Nasir Kato Bashiruddin, Chief Executive Officer of OriCiro.

“We are thrilled to join forces with Moderna to realize the full power of OriCiro for the benefit of patients,” added Seiji Hirasaki, President and Co-founder of OriCiro. – The Health

Tags: AcquisitionForeign NewsModernaOriCiro Genomics K.K.The Health 2023The Health Jan/Feb 2023theHealth
Previous Post

The people’s mandate

Next Post

Trial for malaria vaccine

Live Edition Paper

JUNE 2023 ePaper

MAY 2023 ePaper

 

Subscribe for free complimentary live editions:

Recent News

  • Business unusual
    October 21, 2021
    People are hoping the government will bring about changes in managing the […]
  • Serving better eye-health through scientific innovation
    January 3, 2023
    J&J Vision is committed to serving world-class innovations to provide the […]
  • Hesitancy an old phenomenon
    October 21, 2021
    The World Health Organisation (WHO) defines vaccine hesitancy as a delay in […]
  • MYEG teams with Zhifei on halal Covid-19 vaccine
    January 1, 2021
    MYEG Services Berhad (MYEG) has entered a cooperation with Anhui Zhifei Longcom […]
  • Quick recovery
    February 7, 2022
    Current circumcision methods make the procedure painless and provide a quicker […]

Connect

Office

Revon Media Sdn Bhd
A-5-1, Block A, Parklane Commercial Hub,
Jalan SS 7/26, SS7, 47301 Petaling Jaya,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 7886 6091
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist